Trials / Not Yet Recruiting
Not Yet RecruitingNCT07099742
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
A Study of Real-World Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM) in Bangladesh
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 364 (estimated)
- Sponsor
- Dr. Md. Alimur Reza · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multicenter, real-world study conducted in Bangladesh to assess the effectiveness and safety of Tirzepatide compared to structured lifestyle interventions, including dietary modifications and exercise, in obese adults with or without Type 2 Diabetes Mellitus (T2DM). The study aims to determine whether treatment with Tirzepatide results in superior weight reduction outcomes compared to lifestyle-based approaches. Adult participants (≥18 years) with a body mass index (BMI) ≥25 kg/m² and no prior exposure to GLP-1 receptor agonists will be enrolled at the discretion of the treating physician. Eligible participants will receive either once-weekly Tirzepatide or participate in lifestyle intervention programs aligned with standard clinical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tirzepatide | Exposure |
| BEHAVIORAL | Life Style Modification | Referent group - Lifestyle interventions, exercise, and diet control |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-04-01
- Completion
- 2026-07-01
- First posted
- 2025-08-01
- Last updated
- 2025-08-03
Locations
3 sites across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT07099742. Inclusion in this directory is not an endorsement.